Article Details

Accelerate Diagnostics, Inc. (NASDAQ:AXDX): Why Investors Shouldn't Ditch AXDX stock in 2020

Retrieved on: 2020-11-28 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Accelerate Diagnostics, Inc. (NASDAQ:AXDX): Why Investors Shouldn't Ditch AXDX stock in 2020. View article details on hiswai:

Excerpt

<b>Blackrock Inc</b>. holds the second largest percentage of outstanding shares, with 3.91% or 2.23 Million shares worth $23.8 Million as of Sep 29, 2020.

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up